Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/tethis-spa-collaborates-with-weill-cornell-medicine-to-advance-cellular-residual-disease-monitoring-in-early-stage-breast-cancer-302235952.html
en | boerse | 67924787 |
